RxDoctor Payments Data

Mihaela Onciu, MD

Anatomic Pathology · Memphis, TNNPI 1962405746

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Adaptive Biotechnologies Corporation at 34.4% of the total.

$473in general payments, 2019–2025

Across 15 payments — averaging $31.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Adaptive Biotechnologies Corporation$163
  • Blueprint Medicines Corporation$112
  • Merck$62
  • Roche Diagnostics Corporation$48
  • Caris MPI, Inc.$23
  • Seagen Inc.$18
  • plus $48 from 3 others

What the payments were for

  • Food & beverage$473100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$473 in reported general payments places this provider in the 75th percentile of 29 anatomic pathology providers in Tennessee.

See all anatomic pathology providers in Tennessee

Medicare billing

Part B allowed, 2024
$153,042
Medicare patients
242
Services billed
2,000

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →